Imaging assessment of toxicity related to immune checkpoint inhibitors

In recent years, a wide range of cancer immunotherapies have been developed and have become increasingly important in cancer treatment across multiple oncologic diseases. In particular, immune checkpoint inhibitors (ICIs) offer promising options to improve patient outcomes. However, a major limitati...

Descripción completa

Detalles Bibliográficos
Autores principales: Berz, Antonia M., Boughdad, Sarah, Vietti-Violi, Naïk, Digklia, Antonia, Dromain, Clarisse, Dunet, Vincent, Duran, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995973/
https://www.ncbi.nlm.nih.gov/pubmed/36911692
http://dx.doi.org/10.3389/fimmu.2023.1133207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995973/
https://www.ncbi.nlm.nih.gov/pubmed/36911692
http://dx.doi.org/10.3389/fimmu.2023.1133207

Ejemplares similares